Humanized CD19-specific CAR T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Humanized CD19-specific CAR T cells, covering 2025-12-17 to 2025-12-17. Get the full timeline:
Most recent: Clinical Trial Update: Humanized CD19-Specific CAR T Cells for the Treatment of Patients With Positive Relapsed or Refractory CD19 Positive B-Cell Acute Lymphoblastic Leukemia [Phase 1]